Posts

Posted on

Cisco Announces December 2020 Events with the Financial Community

PR Newswire

SAN JOSE, Calif., Nov. 30, 2020 /PRNewswire/ — Cisco today announced that it will participate in the following conferences with the financial community during the month of December. These sessions will be webcast.  Interested parties can view these events on Cisco’s Investor Relations website at investor.cisco.com.

Raymond James Technology Investors Conference

December 7, 2020

12:20 p.m. PT / 3:20 p.m. ET
Gee Rittenhouse, Sr. Vice President and General Manager, Security Business Group

Barclays Global Technology, Media and Telecommunications Conference

December 9, 2020

11:00 a.m. PT / 2:00 p.m. ET
Bill Gartner, Sr. Vice President and General Manager, Optical Systems and Optics Group

About Cisco

Cisco (NASDAQ: CSCO) is the worldwide leader in technology that powers the Internet. Cisco inspires new possibilities by reimagining your applications, securing your data, transforming your infrastructure, and empowering your teams for a global and inclusive future. Discover more on The Network and follow us on Twitter.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco’s trademarks can be found at www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company.


Investor Relations Contact:        


Press Contact:

Marty Palka                                

Robyn Blum

Cisco                                     

Cisco

408-526-6635                      

(408) 853-9848


[email protected]              


[email protected]      

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cisco-announces-december-2020-events-with-the-financial-community-301180674.html

SOURCE Cisco Systems, Inc.

Posted on

Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition

Includes updated data from CPI-818 phase 1/1b trial and pre-clinical results supporting use in autoimmune lymphoproliferative syndrome (ALPS)

BURLINGAME, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that new data on CPI-818, the Company’s ITK inhibitor, will be presented at the 62nd American Society of Hematology (ASH) Annual Meeting & Exposition, which is taking place as an all-virtual event from December 5-8, 2020. This includes a poster presentation covering updated data from the Phase 1/1b clinical trial for T cell lymphoma and an oral presentation covering pre-clinical data demonstrating its potential for the treatment of autoimmune lymphoproliferative syndrome (ALPS), a rare genetic disease.

Details of the Corvus presentations are as follows:


Abstract 95:
 		The ITK Inhibitor CPI-818 Blocks Activation of T Cells from Autoimmune Lymphoproliferative Syndrome (ALPS) Patients and Is Active in a Murine Model of ALPS
Presenter: V. Koneti Rao, MD, FRCPA, ALPS Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH)
Oral Session: 203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Pathogenesis and Immunotherapy
Date and Time: Saturday, December 5, 2020, 1 PM ET
   

Abstract 2068:
 		CPI-818, an Oral Interleukin-2-Inducible T-Cell Kinase Inhibitor, Is Well-Tolerated and Active in Patients with T-Cell Lymphoma
Presenter: Michael S. Khodadoust, MD, PhD, Division of Medical Oncology, Stanford University School of Medicine
Poster Session: 624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Poster II
Date and Time: Sunday, December 6, 2020 available virtually from 10 AM to 6:30 PM ET

About Corvus Pharmaceuticals

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company. Corvus’ lead product candidates are ciforadenant (CPI-444), a small molecule inhibitor of the A2A receptor, and CPI-006, a humanized monoclonal antibody directed against CD73 that has exhibited immunomodulatory activity and activation of immune cells in preclinical studies. These product candidates are being studied in ongoing Phase 1b/2 and Phase 1/1b clinical trials in patients with a wide range of advanced solid tumors. Ciforadenant is being evaluated in a successive expansion cohort Phase 1b/2 trial examining its activity both as a single agent and in combination with an anti-PD-L1 antibody. CPI-006 is being evaluated in a multicenter Phase 1/1b clinical trial as a single agent, in combination with ciforadenant and pembrolizumab. The Company’s third cancer clinical program, CPI-818, is an investigational, oral, small molecule drug that selectively inhibited ITK in preclinical studies, is in a multicenter Phase 1/1b clinical trial in patients with several types of T-cell lymphomas. The Company is also evaluating CPI-006 as a treatment for COVID-19 patients. For more information, visit www.corvuspharma.com.

About CPI-
818

CPI-818 is a small molecule drug given orally that has been shown to selectively inhibit ITK (interleukin-2-inducible T-cell kinase). It was developed to possess dual properties: to block malignant T-cell growth and modulate immune responses. ITK, an enzyme, is expressed predominantly in T-cells and plays a role in T-cell and natural killer (NK) cell lymphomas and leukemias, as well as in normal immune function. Interference with ITK signaling can modulate immune responses to various antigens. The inhibition of specific molecular targets in T-cells may be of therapeutic benefit for patients with T-cell lymphomas and in patients with autoimmune diseases. The Company is conducting a Phase 1 dose escalation trial in patients with refractory T-cell lymphomas.

INVESTOR CONTACT:

Leiv Lea
Chief Financial Officer
Corvus Pharmaceuticals, Inc.
+1-650-900-4522
[email protected]

MEDIA CONTACT:

Sheryl Seapy
W2O pure
+1-949-903-4750
[email protected]



Posted on

Kiniksa Announces Preliminary Data from Phase 1 Trial of KPL-404

–
R
eceptor occupancy and TDAR suppression
shown
through Day 29 at 3 mg/kg intravenous
–

– Data
to-date
support
subsequent study in patients, including
potential
intravenous or subcutaneous
monthly
administration
–


–
Final data
and safety follow-up from all cohorts
expected in 1H 2021 –

HAMILTON, Bermuda, Nov. 30, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a pipeline of assets designed to modulate immunological pathways across a spectrum of diseases, today announced preliminary data from the Phase 1 clinical trial of KPL-404 in healthy volunteers. KPL-404 is a monoclonal antibody inhibitor of the CD40-CD40 ligand (CD40L) interaction, a central control node of T-cell dependent, B-cell mediated humoral adaptive immunity.

“The preliminary data from the single-ascending-dose Phase 1 study of KPL-404 are encouraging,” said Sanj K. Patel, Chief Executive Officer and Chairman of the Board of Kiniksa. “We believe the data generated to-date suggest that KPL-404 has the potential to address a broad range of autoimmune diseases. We expect final data and safety follow-up from all cohorts of the Phase 1 study in the first half of 2021.”

The Phase 1 trial of KPL-404 is a randomized, double-blind, placebo-controlled, single-ascending-dose, first-in-human study that is divided into two parts: a single dose of KPL-404 0.03 mg/kg, 0.3 mg/kg, 1 mg/kg, 3 mg/kg or 10 mg/kg intravenously (IV) and a single dose of KPL-404 1 mg/kg or 5 mg/kg subcutaneously (SC). The primary objective is to assess the safety and tolerability of KPL-404. Secondary endpoints include pharmacokinetics, CD40 receptor occupancy (RO), the immune response to the novel test antigen keyhole limpet hemocyanin (KLH) in clinically relevant dose cohorts, and the anti-drug antibody response.

All dose escalations occurred as per protocol with no dose limiting safety findings. All 6 subjects dosed with KPL-404 3 mg/kg IV showed full receptor occupancy through Day 29, which corresponded with complete suppression of the T-cell Dependent Antibody Response (TDAR) to KLH through Day 29. Consistent dose relatedness was shown in the lower dose level cohorts, including 0.03 mg/kg, 0.3 mg/kg, 1 mg/kg IV and 1 mg/kg SC. Data collection for the higher dose level cohorts, 10 mg/kg IV and 5 mg/kg SC, is ongoing.

The data to-date support subsequent study in patients, including potential IV or SC monthly administration. Kiniksa expects final data and safety follow-up from all cohorts in the first half of 2021.

The CD40-CD40L interaction has been implicated in diseases such as rheumatoid arthritis, Sjogren’s syndrome, Graves’ disease, and systemic lupus erythematosus and in prevention of solid organ transplant graft rejection, where external proof-of-concept has been previously shown.

“KPL-404 is designed to inhibit CD40-CD40L interaction, a key T-cell co-stimulatory signal pathway critical for B-cell maturation and immunoglobulin class switching. Additionally, dysregulation of the CD40-CD40L pathway has been implicated in multiple autoimmune disease pathologies and has broad reaching implications beyond humoral immunity, with its impact on dendritic cells and macrophage activity,” said John F. Paolini, MD, PhD, Chief Medical Officer of Kiniksa. “The preliminary Phase 1 data replicate and underscore the preclinical data from this program, which showed favorable pharmacokinetic and pharmacodynamic profiles, including suppression of TDAR. The data to-date support continued clinical development, and we look forward to further analyzing the totality of the dataset.”

About KPL-404

KPL-404 is an investigational humanized monoclonal antibody that is designed to inhibit CD40-CD40L interaction, a key T-cell co-stimulatory signal critical for B-cell maturation and immunoglobulin class switching and Type 1 immune responses. Kiniksa believes disrupting the CD40-CD40L interaction is an attractive approach for multiple autoimmune disease pathologies such as rheumatoid arthritis, Sjogren’s syndrome, Graves’ disease, systemic lupus erythematosus and solid organ transplant. Kiniksa owns or controls the intellectual property related to KPL-404.

About
Kiniksa

Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s clinical-stage product candidates, rilonacept, mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved conditions and offer the potential for differentiation. These pipeline assets are designed to modulate immunological pathways across a spectrum of diseases. For more information, please visit www.kiniksa.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions, although not all forwardlooking statements contain these identifying words. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation, statements regarding: our belief that KPL-404 has the potential to address a broad range of autoimmune diseases; our belief that the data to-date from our Phase 1 clinical trial of KPL-404 in healthy volunteers support continued clinical development; expected timing of final data and safety follow-up from all cohorts of the Phase 1 trial in the first half of 2021; our beliefs about the mechanisms of action of our product candidates and potential impact of their approach, including our belief that KPL-404’s disruption of the CD40-CD40L interaction is an attractive approach for multiple autoimmune disease pathologies; and our belief that all of our product candidates offer the potential for differentiation.

These forward-looking statements are based on management’s current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including without limitation, the following: delays or difficulty in completing our Phase 1 clinical trial of KPL-404 in healthy volunteers; potential for changes between final data and any preliminary, interim, top-line or other data from the Phase 1 clinical trial; our potential inability to replicate in later clinical trials the positive final data from our earlier clinical trials or studies; impact of additional data from us or other companies, including the potential for our data to produce negative, inconclusive or commercially uncompetitive results; potential undesirable side effects caused by KPL-404; our reliance on third parties to manufacture our product candidates; drug substance and/or drug product shortages; our reliance on third parties to conduct research, clinical trials, and/or certain regulatory activities for our product candidates, including for KPL-404; potential complications in coordinating requirements, regulations and guidelines of regulatory authorities across jurisdictions for our clinical trials, including for the Phase 1 clinical trial; the potential impact of the COVID-19 pandemic and measures taken in response to the pandemic on our business and operations as well as the business and operations of our manufacturers, CROs upon whom we rely to conduct our clinical trials, and other third parties with whom we conduct business or otherwise engage, including the FDA and other regulatory authorities; changes in our operating plan and funding requirements; and existing or new competition.

These and other important factors discussed under the caption “Risk Factors” in our Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on November 5, 2020 and our other reports subsequently filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.


Every Second


Counts!™

Kiniksa
Investor and Media Contact

Mark Ragosa
(781) 430-8289
[email protected] 



Posted on

TESSCO Special Committee Reiterates Call to Prevent Mr. Barnhill from Naming a Majority of the Board

TESSCO Special Committee Reiterates Call to Prevent Mr. Barnhill from Naming a Majority of the Board

Mr. Barnhill’s Unwillingness to Consider the Special Committee’s Reasonable Settlement Proposal Confirms His True Aim is Control of TESSCO’s Board

Shareholders Should Support the Settlement Proposal by Refusing to Consent to Hand Mr. Barnhill and His Nominees Control of the Board

HUNT VALLEY, Md.–(BUSINESS WIRE)–
TESSCO Technologies Incorporated (NASDAQ: TESS), a leading value-added distributor and solutions provider for the wireless industry, today issued the following statement on behalf of the Special Committee of the Board of Directors in response to Robert B. Barnhill, Jr.’s continued unwillingness to engage in settlement discussions:

On November 23, 2020, TESSCO made its third settlement proposal to Mr. Barnhill in an attempt to reach a resolution to his ongoing consent solicitation. The proposal would result in a Board composed of Mr. Barnhill, two of his nominees, TESSCO’s Chief Executive Officer, Sandip Mukerjee, the three directors who were added to the TESSCO Board in 2020 as the result of a comprehensive director search conducted with the assistance of a leading executive search firm, and Paul Gaffney, who joined the Board in 2018. The other terms of the settlement proposal are standard and customary.

If accepted, the proposal would result in the entirety of the Board being replaced since 2018, other than Mr. Barnhill whose tenure spans nearly 40 years. The resulting Board composition would align with the preferred outcomes of independent proxy advisory firms Institutional Shareholder Services (“ISS”) and Glass Lewis & Co. (“Glass Lewis”), as indicated in their respective, recent reports. Importantly, both ISS and Glass Lewis indicated that shareholders would not be best served by Mr. Barnhill and his nominees obtaining control of the Board.

Mr. Barnhill has not responded to the proposal or made any other effort to find a way to end the expensive and disruptive consent solicitation. We believe it is critical to deliver a lasting peace so that Mr. Mukerjee and the management team are afforded the time and room they deserve to focus on the strategic plan and turn TESSCO around. Mr. Barnhill’s refusal to respond or consider a settlement proposal that two independent advisory firms believe is ideal suggests Mr. Barnhill is not seeking what is best for TESSCO, but is instead focused on securing control of the TESSCO Board.

Shareholders should consider why Mr. Barnhill is so focused on obtaining a majority of the Board seats. Under our settlement proposal, Mr. Barnhill would need to convince just two directors (in addition to two of his nominees that would be elected to the Board under the proposal) that any future course of action is good for the Company. Why is Mr. Barnhill so fearful that he will not be able to do so?

Shareholders should be particularly concerned given that earlier this year Mr. Barnhill took steps to acquire the Company, and in so doing refused to abide by appropriate and conventional procedures to ensure such a transaction would be fair to all shareholders. Nothing prevents Mr. Barnhill from again seeking to acquire or take TESSCO private. In such case, the best way to assure the best price for all shareholders is to follow a fair process administered by a Board that is not controlled by Mr. Barnhill and his hand-picked nominees. If Mr. Barnhill wants to buy TESSCO, he should have to convince directors that are independent of his influence that such a transaction is in the interest of all shareholders.

If shareholders consent to Mr. Barnhill’s plan, Mr. Barnhill will re-establish a significant position of influence at TESSCO, which has not served TESSCO well over the past decade. With a hand-picked Board, Mr. Barnhill will likely have latitude to retain excessive influence on the Board, despite Mr. Barnhill’s lack of new ideas (as confirmed by both ISS and Glass Lewis) and an exceptional CEO that needs the flexibility to turn TESSCO around, including by reversing some of the value-destructive decisions made by Mr. Barnhill during his tenures as CEO and as Executive Chairman.

We urge shareholders to protect the future of their investment and prevent Mr. Barnhill and his nominees from gaining control of the TESSCO Board by signing, dating and returning the enclosed GREEN Consent Revocation Card TODAY.

TESSCO shareholders are reminded that their vote is important, no matter how many or how few shares they own. TESSCO urges you to support the TESSCO settlement proposal and your company’s Board by signing, dating and returning the enclosed GREEN Consent Revocation Card TODAY. If you receive a White Consent Card from Robert B. Barnhill, Jr., please disregard it.

If you have any questions or need assistance executing your revocation,

please contact TESSCO’s proxy solicitor,

Innisfree M&A Incorporated

Shareholders may call toll-free: (877) 800-5195

Banks and Brokers may call collect: (212) 750-5833

Sidley Austin LLP and Ballard Spahr LLP are serving as legal counsel to the Special Committee of TESSCO’s Board of Directors.

About TESSCO Technologies Incorporated (NASDAQ: TESS)

TESSCO Technologies, Inc. (NASDAQ: TESS) is a value-added technology distributor, manufacturer, and solutions provider serving commercial and retail customers in the wireless infrastructure and mobile device accessories markets. The company was founded more than 30 years ago with a commitment to deliver industry-leading products, knowledge, solutions, and customer service. TESSCO supplies more than 46,000 products from 350 of the industry’s top manufacturers in mobile communications, Wi-Fi, Internet of Things (“IoT”), wireless backhaul, and more. TESSCO is a single source for outstanding customer experience, expert knowledge, and complete end-to-end solutions for the wireless industry. For more information, visit www.tessco.com.

Forward-Looking Statements

This release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained herein, including statements regarding our future results of operations and financial position, strategy and plans and future prospects, and our expectations for future operations, are forward-looking statements. These forward-looking statements are based on current expectations and analysis, and actual results may differ materially from those projected. These forward-looking statements may generally be identified by the use of the words “may,” “will,” “expects,” “anticipates,” “targets,” “goals,” “projects,” “intends,” “plans,” “seeks,” “believes,” “estimates,” and similar expressions, but the absence of these words or phrases does not necessarily mean that a statement is not forward-looking. These forward-looking statements are only predictions and involve a number of risks, uncertainties and assumptions, many of which are outside of our control. Our actual results may differ materially and adversely from those described in or contemplated by any such forward-looking statement for a variety of reasons, including those risks identified in our most recent Annual Report on Form 10-K and other periodic reports filed with the Securities and Exchange Commission (the “SEC”), under the heading “Risk Factors” and otherwise. Consequently, the reader is cautioned to consider all forward-looking statements in light of the risks to which they are subject. For additional information with respect to risks and other factors which could occur, see Tessco’s Annual Report on Form 10-K for the year ended March 29, 2020, including Part I, Item 1A, “Risk Factors” therein, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other securities filings with the SEC that are available at the SEC’s website at www.sec.gov and other securities regulators.

We are not able to identify or control all circumstances that could occur in the future that may materially and adversely affect our business and operating results. Without limiting the risks that we describe in our periodic reports and elsewhere, among the risks that could lead to a materially adverse impact on our business or operating results are the following: the impact and results of the consent solicitation and other activism activities by Robert B. Barnhill, Jr. and certain other participants in his consent solicitation and/or other activist investors, termination or non-renewal of limited duration agreements or arrangements with our vendors and affinity partners that are typically terminable by either party upon several months or otherwise relatively short notice; loss of significant customers or relationships, including affinity relationships; loss of customers either directly or indirectly as a result of consolidation among large wireless services carriers and others within the wireless communications industry; the strength of our customers’, vendors’ and affinity partners’ business; negative or adverse economic conditions, including those adversely affecting consumer confidence or consumer or business spending or otherwise adversely impacting our vendors or customers, including their access to capital or liquidity, or our customers’ demand for, or ability to fund or pay for, the purchase of our products and services; our dependence on a relatively small number of suppliers and vendors, which could hamper our ability to maintain appropriate inventory levels and meet customer demand; changes in customer and product mix that affect gross margin; effect of “conflict minerals” regulations on the supply and cost of certain of our products; failure of our information technology system or distribution system; system security or data protection breaches; technology changes in the wireless communications industry or technological failures, which could lead to significant inventory obsolescence and/or our inability to offer key products that our customers demand; third-party freight carrier interruption; increased competition from competitors, including manufacturers or national and regional distributors of the products we sell and the absence of significant barriers to entry which could result in pricing and other pressures on profitability and market share; our relative bargaining power and inability to negotiate favorable terms with our vendors and customers; our inability to access capital and obtain financing as and when needed; transitional and other risks associated with acquisitions of companies that we may undertake in an effort to expand our business; claims against us for breach of the intellectual property rights of third parties; product liability claims; our inability to protect certain intellectual property, including systems and technologies on which we rely; our inability to hire or retain for any reason our key professionals, management and staff; health epidemics or pandemics or other outbreaks or events, or national or world events or disasters beyond our control; and the possibility that, for unforeseen or other reasons, we may be delayed in entering into or performing, or may fail to enter into or perform, anticipated contracts or may otherwise be delayed in realizing or fail to realize anticipated revenues or anticipated savings.

The above list should not be construed as exhaustive and should be read in conjunction with our other disclosures, including but not limited to the risk factors described in our most recent Annual Report on Form 10-K and other periodic reports filed with the SEC, under the heading “Risk Factors” and otherwise. Other risks may be described from time to time in our filings made under the securities laws. New risks emerge from time to time. It is not possible for our management to predict all risks.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. In addition, neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Any forward-looking statement made by us in this press release speaks only as of the date on which it is made. We disclaim any duty to update any of these forward-looking statements after the date of this press release to confirm these statements to actual results or revised expectations.

Important Additional Information and Where to Find It

In connection with the consent solicitation initiated by Robert B. Barnhill, Jr. and certain other participants, TESSCO Technologies Incorporated (the “Company”) has filed a consent revocation statement and accompanying GREEN consent revocation card and other relevant documents with the Securities and Exchange Commission (the “SEC”). SHAREHOLDERS ARE STRONGLY ENCOURAGED TO CAREFULLY READ THE COMPANY’S CONSENT REVOCATION STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO), ACCOMPANYING GREEN CONSENT REVOCATION CARD AND ALL OTHER DOCUMENTS FILED WITH THE SEC IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION. Shareholders may obtain a free copy of the consent revocation statement, any amendments or supplements to the consent revocation statement and other documents that the Company files with the SEC at the SEC’s website at www.sec.gov or the Company’s website at https://ir.tessco.com as soon as reasonably practicable after such materials are electronically filed with, or furnished to, the SEC.

Cindy King, TESSCO

+1 410 229 1161 or [email protected]

Media

Jeff Kauth / Aiden Woglom

Joele Frank Wilkinson Brimmer Katcher

(212) 355-4449

Investors

Larry Miller / Gabrielle Wolf

Innisfree M&A Incorporated

Phone: (212) 750-5833

KEYWORDS: Maryland United States North America

INDUSTRY KEYWORDS: Technology Mobile/Wireless Internet Other Technology

MEDIA:

Posted on

VICI Properties Announces Donation of Bluegrass Downs

VICI Properties Announces Donation of Bluegrass Downs

NEW YORK–(BUSINESS WIRE)–
VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or the “Company”) announced that it has agreed to gift nearly 58 acres of land that formerly housed the Bluegrass Downs Race Track, located in Paducah, KY, to McCracken County. The land will be used as a youth recreational sports complex for soccer, baseball and softball to benefit roughly 1,200 children in the local area. Bluegrass Downs ceased operations in October 2019. This transaction does not impact any of the Company’s lease agreements.

John Payne, President and Chief Operating Officer of VICI Properties, said, “VICI is glad to be able to make this donation, which will directly benefit the communities in Paducah and McCracken County.”

Craig Clymer, McCracken County Judge-Executive, said, “We are delighted. The location is perfect for our needs. For decades, kids have been playing soccer at the old landfill site. This gives us the opportunity to dramatically improve our situation. We have heard from so many parents about traveling on weekends to play in other cities. Now we have a chance to attract others to McCracken County. I wish to thank VICI for its generous contribution.”

About VICI Properties

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties’ national, geographically diverse portfolio consists of 28 gaming facilities comprising 47 million square feet and features approximately 18,000 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars, Century Casinos, Hard Rock International, JACK Entertainment and Penn National Gaming. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties’ strategy is to create the nation’s highest quality and most productive experiential real estate portfolio. For additional information, please visit www.viciproperties.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. You can identify these statements by our use of the words “anticipates,” “assumes,” “believes,” “estimates,” “expects,” “guidance,” “intends,” “plans,” “projects,” and similar expressions that do not relate to historical matters. All statements other than statements of historical fact are forward-looking statements. You should exercise caution in interpreting and relying on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors which are, in some cases, beyond the Company’s control and could materially affect actual results, performance, or achievements. Among those risks, uncertainties and other factors are the impact of changes in general economic conditions, including low consumer confidence, unemployment levels and depressed real estate prices resulting from the severity and duration of any downturn in the U.S. or global economy (including stemming from the COVID-19 pandemic and changes in the economic conditions as a result of the COVID-19 pandemic).

Although the Company believes that in making such forward-looking statements its expectations are based upon reasonable assumptions, such statements may be influenced by factors that could cause actual outcomes and results to be materially different from those projected. The Company cannot assure you that the assumptions upon which these statements are based will prove to have been correct. Additional important factors that may affect the Company’s business, results of operations and financial position are described from time to time in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, Quarterly Reports on Form 10-Q and the Company’s other filings with the Securities and Exchange Commission. The Company does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required by applicable law.

Investor Contacts:

[email protected]

(646) 949-4631

Or

David Kieske

EVP, Chief Financial Officer

[email protected]


Danny Valoy

Vice President, Finance

[email protected]

Media Contacts:

[email protected]

(646) 949-4631

KEYWORDS: Nevada New York Kentucky United States North America

INDUSTRY KEYWORDS: Banking Entertainment Professional Services Other Construction & Property Residential Building & Real Estate Lodging Destinations Construction & Property Travel Urban Planning Finance Casino/Gaming

MEDIA:

Posted on

J.B. Hunt Announces Acquisition of Mass Movement, Inc., Its Fourth to Expand Final Mile Services Since 2017

J.B. Hunt Announces Acquisition of Mass Movement, Inc., Its Fourth to Expand Final Mile Services Since 2017

LOWELL, Ark.–(BUSINESS WIRE)–
J.B. Hunt Transport Services, Inc. (NASDAQ: JBHT), one of the largest supply chain solutions providers in North America, announced today that its subsidiary, J.B. Hunt Transport, Inc., acquired the assets of Mass Movement, Inc. on November 30.

“Mass Movement presents an opportunity to expand our expertise in the final mile delivery of big and bulky products,” said John Roberts, president and CEO of J.B. Hunt. “The acquisition complements our current service and will enhance our ability to meet the growing demand of customers in the commercial health and fitness industry.”

Mass Movement has more than 20 years of experience providing logistics, delivery, assembly, and installation services for the commercial fitness industry and finished 2019 with $29 million of revenue. Founded by Dom Simonetti and Jim Sullivan in 1996, the company has delivered two million-plus pieces of equipment to more than 3,500 fitness centers throughout North America. Both founders will become employees of J.B. Hunt and will continue in leadership roles as the company expands its fitness equipment delivery business.

“Mass Movement is highly regarded among industry manufacturers and facility owners,” said Nick Hobbs, executive vice president and president of Dedicated Contract Services and Final Mile Services. “Its reputation and service quality align with ours, and we look forward to welcoming Mass Movement’s employees to the J.B. Hunt family.”

The acquisition is J.B. Hunt’s fourth since 2017 and will broaden the company’s industry-leading Final Mile Services, which operates one of the largest nationwide, commingled cross-dock operations. With 117 locations and over 3.4 million square feet of warehouse and facilities space, Final Mile has the ability to serve 100% of the contiguous United States. In 2019, J.B. Hunt acquired the assets of RDI Last Mile Co. and Cory 1st Choice Home Delivery. The company also purchased Special Logistics Dedicated in 2017.

The transaction was funded using cash on hand, and the law firm of Mitchell, Williams, Selig, Gates & Woodyard, PLLC served as legal advisor to J.B. Hunt.

About J.B. Hunt

J.B. Hunt Transport Services, Inc., an S&P 500 company, provides innovative supply chain solutions for a variety of customers throughout North America. Utilizing an integrated, multimodal approach, the company applies technology-driven methods to create the best solution for each customer, adding efficiency, flexibility, and value to their operations. J.B. Hunt services include intermodal, dedicated, refrigerated, truckload, less-than-truckload, flatbed, single source, final mile, and more. J.B. Hunt Transport Services, Inc. stock trades on NASDAQ under the ticker symbol JBHT and is a component of the Dow Jones Transportation Average. J.B. Hunt Transport, Inc. is a wholly owned subsidiary of JBHT. For more information, visitwww.jbhunt.com.

Brad Delco

Vice President – Finance and Investor Relations

(479) 820-2723

KEYWORDS: Arkansas United States North America

INDUSTRY KEYWORDS: Trucking Transport Logistics/Supply Chain Management

MEDIA:

Logo
Logo
Posted on

Inseego 5G MiFi® M2000 Now Available in Switzerland on Swisscom’s Nationwide 5G Network

Inseego 5G MiFi® M2000 Now Available in Switzerland on Swisscom’s Nationwide 5G Network

SAN DIEGO & BERN, Switzerland–(BUSINESS WIRE)–
Inseego Corp. today announced that it has partnered with Switzerland’s leading telecommunications and IT company, Swisscom, to bring the Inseego 5G MiFi® M2000 mobile hotspot to Swisscom’s nationwide live 5G network.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201130005418/en/

Inseego 5G MiFi M2000 Lands in Switzerland (C)2020. Inseego Corp.

Inseego 5G MiFi M2000 Lands in Switzerland (C)2020. Inseego Corp.

The Inseego 5G MiFi M2000 mobile hotspot is the first commercially available 5G MiFi mobile hotspot built on second-generation 5G technology, delivering blazing-fast speeds and seamless connectivity across 5G sub-6 and 4G LTE networks available in Europe. With support for Dynamic Spectrum Sharing (DSS), the 5G MiFi M2000 delivers the best available combination for speed, performance, and coverage.

“With its ultra-fast, robust broadband connections and low latency, 5G – the latest generation of mobile communications – opens up a whole host of new possibilities,” said Nicolas Müntener, Head of Device Management at Swisscom. “As the first European provider – and the fifth in the world – to go live with a 5G network, we are excited to expand our device lineup with the latest generation mobile hotspot and provide our customers a superior 5G experience.”

Groundbreaking technology meets breakthrough performance

With Inseego’s proprietary advanced RF technology design, the Inseego 5G MiFi M2000 series delivers gigabit-plus* data speeds in sub-6 GHz bands. It also supports new applications requiring the responsiveness and ultra-low latency that 5G technology enables.

“Global demand across our entire 5G portfolio of mobile broadband and fixed wireless solutions is very strong and continues to rapidly grow. Our high-performance 5G products are the gold standard with blazing fast speed, ultra-low latency and the most advanced cyber security features in the industry,” said Simon Rayne, Senior Vice President and Managing Director, UK, EMEA, and Asia-Pacific at Inseego. “With the introduction of our industry-leading second-generation 5G MiFi mobile hotspot to Swisscom’s device lineup, consumers and enterprise users will be able to enjoy new experiences and applications that drive greater business value.”

The Inseego 5G MiFi M2000 mobile hotspot provides a complete and secure 5G experience, allowing Swisscom customers to:

  • Stop the bottlenecks with Wi-Fi 6 – The 5G MiFi M2000 uses efficient, simultaneous, dual-band Wi-Fi 6 technology which offers up to 4x greater throughput per user* and significantly faster speeds for connected devices compared to Wi-Fi 5, with secure connections for up to 30 Wi-Fi enabled devices.
  • Connect with enterprise-grade security – Designed and developed in the USA, the 5G MiFi M2000 series provides multiple layers of protection with the latest WPA 3 Wi-Fi security protocol, advanced encryption, hacker prevention, password protection, Guest Wi-Fi network, VPN pass-through and Open VPN.
  • Turn any Wi-Fi enabled device into a 5G powerhouse, easily – With a large 2.4” touchscreen color display and simple menus supporting multiple languages, the plug-and-play 5G MiFi 2000 makes it easy to stay connected all day* to laptops, smartphones, and tablets and other Wi-Fi enabled devices, and view important information and protect data.
  • Push the boundaries with 5G – From data-hungry consumers to remote workers to cutting-edge enterprise applications, the 5G MiFi M2000provides ultra-fast, secure, reliable 5G connectivity for a world of exciting new applications that demand low latency and exponential capacity in the areas of healthcare, emergency response, manufacturing, education, and entertainment, among others.

*Actual speeds and coverage may vary. 4x higher Wi-Fi 6 throughput per user when multiple devices are connected. Battery life and charge time may vary depending on the number of connected devices and activity. Inseego 5G MiFi M2000 chipset: Qualcomm® Snapdragon® X55 5G Modem-RF System.

MEDIA: To learn more about Inseego 5G solutions or schedule an executive interview, please contact [email protected].

About Inseego Corp.

Inseego Corp. (Nasdaq: INSG) is an industry pioneer in smart device-to-cloud solutions that extend the 5G network edge, enabling broader 5G coverage, multi-gigabit data speeds, low latency and strong security to deliver highly reliable internet access. Our innovative mobile broadband and fixed wireless access (FWA) solutions incorporate the most advanced technologies (including 5G, 4G LTE, Wi-Fi 6 and others) into a wide range of products that provide robust connectivity indoors, outdoors and in the harshest industrial environments. Designed and developed in the USA, Inseego products and SaaS solutions build on the company’s patented technologies to provide the highest quality wireless connectivity for service providers, enterprises, and government entities worldwide. www.inseego.com

About Swisscom

Swisscom, Switzerland’s leading telecoms company and one of its leading IT companies, is headquartered in Ittigen, close to the capital city Bern. Outside Switzerland, Swisscom has a presence on the Italian market in the guise of Fastweb. In the first half of 2020, about 19,000 employees generated sales of CHF 5,443 million. It is 51% Confederation-owned and is one of Switzerland’s most sustainable and innovative companies.

©2020 Inseego Corp. All rights reserved. The Inseego name and logo are trademarks of Inseego Corp. MiFi is a registered trademark of Inseego Corp. in the United States and other countries.

Qualcomm Snapdragon is a product of Qualcomm Technologies, Inc. and/or its subsidiaries. Qualcomm and Snapdragon, are trademarks or registered trademarks of Qualcomm Incorporated.

Other Company, product or service names mentioned herein are the trademarks of their respective owners.

Media contact:

Anette Gaven

Tel: +1 (619) 993-3058

Email: [email protected]

Or

Investor Relations contact:

Joo-Hun Kim, MKR Group

Tel: +1 (212) 868-6760

Email: [email protected]

KEYWORDS: California Switzerland Austria Germany North America Europe United States Ireland United Kingdom

INDUSTRY KEYWORDS: Data Management Consumer Electronics Technology Telecommunications Software Networks Audio/Video Internet VoIP Mobile/Wireless Hardware

MEDIA:

Logo
Logo
Photo
Photo
Inseego 5G MiFi M2000 Lands in Switzerland (C)2020. Inseego Corp.
Posted on

Elys Game Technology Comments on Canadian Legislation to Legalize Single-Event Sports Wagering in Canada

Elys Game Technology Comments on Canadian Legislation to Legalize Single-Event Sports Wagering in Canada

NEW YORK–(BUSINESS WIRE)–Elys Game Technology, Corp. (“Elys” or the “Company”) (Nasdaq:ELYS), an interactive gaming and sports betting technology company, today commented on proposed Canadian Federal Government legislation to legalize single-event sports wagering in Canada (Bill C-13 “An Act to amend the Criminal Code (single event sport betting).”

The proposed changes would give provinces and territories the ability to offer single-event sport betting products and the discretion to manage single-event sport betting in their respective jurisdictions. In provinces and territories that choose to offer single-event sport betting, Canadians would have an opportunity to engage in this activity in a regulated environment, either online or in physical facilities.

“We commend Canada’s Minister of Justice and Attorney General for introducing this important legislation in support of single-event sports betting,” stated Michele (Mike) Ciavarella, Chairman and CEO of Elys Game Technology, Corp. “We believe there is strong bi-partisan support for this bill and, if passed, would have a very positive impact for both Elys, given our strong leadership in the space, as well as the overall industry, which has been negatively impacted by the COVID-19 pandemic. We estimate that approximately CDN$80 Billion is wagered on sports each year in Canada. With our established relationship foothold in Canada, sportsbook experience and cutting-edge Elys betting technology, we believe there is a tremendous opportunity to expand our business across the provinces.”

About Elys Game Technology, Corp.

Elys Game Technology, Corp., is a B2B global gaming technology company operating in multiple countries worldwide, with B2C online and land-based gaming operations in Italy. In Italy, Elys offers its clients a full suite of leisure gaming products and services, such as sports betting, e-sports, virtual sports, online casino, poker, bingo, interactive games and slots.

The Company’s innovative wagering solution services online operators, casinos, retail betting establishments and franchise distribution networks. The Company has completed the product regulatory requirements to commence B2B operations in the United States. Additional information is available on our corporate website at www.elysgame.com.

Investors may also find us on Twitter @ELYS_gaming.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of the words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “may,” “continue,” “predict,” “potential,” “project” and similar expressions that are intended to identify forward-looking statements and include statements regarding strong bi-partisan support for the proposed Canadian Federal Government legislation to legalize single-event sports wagering in Canada, the positive impact for both Elys, as well as the overall industry, if the bill is passed, approximately CDN$80 Billion being wagered on sports each year in Canada and the opportunity to expand the Company’s business across the provinces. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the Company’s ability to offer single-event sport betting products and the discretion to manage single-event sport betting to Canadians as contemplated by the legislation, having strong bi-partisan support to pass the legislation, the legislation, if passed, having the positive impact for Elys as expected; the wagering of CDN$80 Billion sports each year in Canada as expected; the Company’s ability to expand its business across the provinces as planned, the duration and scope of the COVID-19 outbreak worldwide, including the impact to the state and local economies, and the risk factors described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and its subsequent filings with the U.S. Securities and Exchange Commission, including subsequent periodic reports on Form 10-Q and current reports on Form 8-K. The information in this release is provided only as of the date of this release, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events, except as required by law.

Crescendo Communications, LLC

David Waldman

Tel: (212) 671-1020

Email: [email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Data Management Entertainment Sports Technology Other Sports Software Casino/Gaming

MEDIA:

Logo
Logo
Posted on

Blackstone Announces Agreement to Acquire DCI, a Pioneer in Technology-driven, Quantitative Credit Investing

Blackstone Announces Agreement to Acquire DCI, a Pioneer in Technology-driven, Quantitative Credit Investing

NEW YORK–(BUSINESS WIRE)–
Blackstone (NYSE:BX) today announced that it has agreed to acquire DCI, a pioneer in quantitative credit investing with approximately $7.5 billion in AUM across the global investment grade, high yield and emerging corporate credit markets. The firm, based in San Francisco, applies a proprietary, fundamental-based, technology-driven model to deliver differentiated returns to clients. DCI is led by a team of seasoned professionals who are recognized experts in quantitative and systematic fixed income research.

DCI will become part of Blackstone Credit, a global leader in private lending, syndicated leveraged loans and collateralized loan obligations. The transaction will broaden Blackstone Credit’s capabilities in high yield and investment grade, enable the integration of DCI’s models and technology across the combined Blackstone Credit and DCI platforms and increase access to investors via a UCITs platform. DCI’s investment process will benefit from Blackstone’s resources, scale and deep relationships across global financial markets.

Dwight Scott, Global Head of Blackstone Credit, said: “DCI has a more than 15-year track record of developing and applying technology-driven strategies and is at the forefront of the evolution towards quantitative investing in the corporate bond market. DCI will strengthen and differentiate the solutions we provide to our retail, institutional and insurance clients.”

Tim Kasta, CEO of DCI, said: “Joining Blackstone Credit will provide DCI’s team and investors with access to unparalleled institutional resources and asset management expertise and accelerate the development of innovative solutions in corporate credit.”

Blackstone Credit is one of the world’s largest credit-focused asset managers, with $135 billion in AUM and a team of over 350 professionals (as of September 30, 2020). Its strategies cover the corporate credit market, with leading positions in both liquid and private markets.

About DCI

DCI is an independent asset management firm specializing in investment grade, high yield, and emerging market corporate credit strategies. The firm manages long-only and long/short strategies for some of the world’s largest institutional and private wealth investors. DCI deploys a fundamental based, systematic approach seeking to exploit potential inefficiencies in the corporate credit markets. DCI was awarded the Hedge Fund Journal’s “Corporate Credit – Market Neutral, Best Performing Fund in 2019 and over 2, 3, 4, 5, and 7 Year Periods” for the DCI Market Neutral Credit Fund (UCITS). This is the 4th consecutive year DCI has been presented with this award. DCI was co-founded in 2004 by Stephen Kealhofer, Mac McQuown and David Solo.

About Blackstone

Blackstone is one of the world’s leading investment firms. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. We do this by using extraordinary people and flexible capital to help companies solve problems. Our $584 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. Further information is available at www.blackstone.com. Follow Blackstone on Twitter @Blackstone.

Kate Holderness

[email protected]

917-318-6818

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Professional Services Other Professional Services Technology Other Technology Finance Consulting Banking

MEDIA:

Logo
Logo
Posted on

Invictus Global Management Issues Open Letter to Fellow Creditors of Tuesday Morning Corporation

Invictus Global Management Issues Open Letter to Fellow Creditors of Tuesday Morning Corporation

Asserts That Tuesday Morning’s Currently Proposed Reorganization Plan Deprives Class 5 General Unsecured Creditors of a Substantial Amount of Post-Petition Interest

Highlights That the Current Plan Provides a Mere 0.16% of Post-Petition Interest at the Federal Judgment Rate, but Creditors Could be Legally Entitled to 5%-18% Under Contract or State Rates

Urges Fellow Creditors to NOT Cast Their Irrevocable Vote on the Plan Before Considering the Invictus Position

AUSTIN, Texas–(BUSINESS WIRE)–
Invictus Global Management, LLC (together with its affiliates, “Invictus” or “we”), which is a member of the Trade Claimants Committee that filed an objection to the proposed plan of reorganization (the “Reorganization Plan”) of Tuesday Morning Corporation’s (OTC: TUESQ) (“Tuesday Morning” or the “Company”) on November 25, 2020, today issued the below open letter to its fellow creditors. Creditors can visit www.RejectTuesdayMorningPlan.com to view the full objection.

Dear Fellow Class 5 General Unsecured Creditor,

Invictus Global Management (together with its affiliates, “Invictus” or “we”) is a Texas-based firm that provides capital to struggling companies seeking to restructure their debts and pursue turnarounds. We take pride in seeing companies, particularly those based in Texas, return to growth and succeed following difficult periods. When we are asked to support bankruptcy exit plans, we almost always vote “YES” as long as we are treated equitably and fairly.

Unfortunately, Invictus and other major claim holders of Tuesday Morning Corporation (OTC: TUESQ) (“Tuesday Morning” or the “Company”) recently felt compelled to object to the Company’s proposed Reorganization Plan. As noted in our objection, the current version of the Reorganization Plan deprives creditors – such as you and us – of a material amount of post-petition interest. Fortunately, creditors have the opportunity to reject this version.

We intend to vote REJECT the current Reorganization Plan and OPT OUT of the Third-Party Releases for two primary reasons:

  1. Creditors would surrender a significant amount of money. Tuesday Morning is trying to provide creditors a mere 0.16% in the form of post-petition interest at the federal judgment rate on the petition date, whereas creditors may be entitled to between 5% and 18% under contract or state rates under the solvent-debtor exception.1 This could mean forgoing thousands of dollars in potential interest that Tuesday Morning can afford to pay and will be legally required to disburse if sufficient creditors REJECT the present plan iteration. If enough creditors REJECT the Reorganization Plan, we believe Tuesday Morning will need to satisfy its obligations under the solvent-debtor exception that would require the Company to pay its creditors in full before recovering any surplus.2 Here, payment in full means getting 100% in cash + post-petition interest of 5% to 18%.

  2. Creditors would be waiving key safeguards. Tuesday Morning apparently wants creditors to waive safeguards of the Bankruptcy Code and provide stockholders with a windfall to the detriment of general unsecured creditors. This flies in the face of bankruptcy precedent and the fact that creditors are senior in the priority chain to equity holders. The Company is also trying to play games by pegging the federal judgment rate to an uncharacteristically low rate as of the petition date to undercompensate creditors even though it possesses sufficient capital.

Our hope is that all creditors view this letter and our objection as useful resources when independently determining how to vote. If you agree with our assessment, we encourage you to REJECT the current Reorganization Plan and OPT OUT of Third-Party Releases in order to protect your interests. Please consider the following as you consider the information being provided to you:

  • Your vote is irrevocable. Do not vote until you have made a final decision.
  • Voting to REJECT the current Reorganization Plan will not jeopardize your ability to be paid what Tuesday Morning owes you. It will merely provide you all of the money you are entitled to.
  • You can cast your vote via the E-Ballot hosted at the following link: dm.epiq11.com/case/tuesdaymorning/info. You will need your Unique E-Ballot ID#, which appears on your ballot, in order to vote.

Please reach out to our representatives at [email protected] if you have questions about how to REJECT the current Reorganization Plan.

Sincerely,

Amit P. Patel

Managing Partner

Cindy Chen Delano

Partner

1 See Tex. Fin. Code §§ 304.002-304.003.

2 Invictus finds it disingenuous that Tuesday Morning arbitrarily selected the Petition Date as the trigger date for the federal judgment interest rate. Currently, the federal judgment interest rate is 2.59%. The date arbitrarily selected by Debtors was in the height of the global pandemic and at a point in time when the federal judgment rate was uncharacteristically low.

Saratoga Proxy Consulting

John Ferguson / Joe Mills, 212-257-1311

[email protected] / [email protected]

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA: